secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2021-12-21T23:59:59+00:00
Accession:  0001140361-21-042603
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Luba Greenwood resigns from Brooklyn ImmunoTherapeutics board effective Jan 1, 2022
--------------------------------------------------------------------------------

- Luba Greenwood notified board on Dec 16, 2021, of her resignation as director effective Jan 1, 2022.
- Resignation not due to any disagreement with the company’s operations, policies, or practices.
- No replacement has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000114036121042603/0001140361-21-042603-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000114036121042603/brhc10032107_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-21-042603

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer